Food and Drug Administration responses to the challenges of AIDS.

Meyer, H M

[PDF-761.21 KB]

Details:

Personal Authors:

Meyer, H M

Keywords:

[+]

Pubmed ID:

6193550

Pubmed Central ID:

PMCnull

Description:

Rarely has a public health issue emerged that has had impact on so many aspects of the responsibilities of the Food and Drug Administration. In a curious sense, the emergence of AIDS as a national problem has been timely. Only a few years ago, the scientific basis did not exist for performing studies of the immunology and pathogenesis of the syndrome--studies that should be helpful in directing therapeutic and preventive measures. Many of the techniques for studying AIDS and for manufacturing products to treat it involve modern technology. Research and policy actions that FDA has initiated have been designed to ensure as fully as possible the safety and effectiveness of regulated products that are relevant to AIDS and to apply new technology to this important public health problem.

Document Type:

Journal Article

Collection(s):

Public Health Reports

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

You May Also Like:

Public Health Reports ; v. 113, no. 6 : 1998 index

Published:

Nov-Dec 1998

Source:

Public Health Rep. 113(6)

Description:

Includes masthead for v. 113, no. 6.

File Type:

[PDF - 3.32 MB]
Immunology careers at the NIH, FDA and CDC: different paths that focus on advancing public health

Personal Author:

Catalfamo, Marta; Mawle, Alison; Verthelyi, Daniela;

Published:

Feb 2015

Source:

Nat Immunol. 16(2):129-132.

File Type:

[PDF - 368.98 KB]
PrEP implementation by local health departments in US cities and counties: Findings from a 2015 assessment of local health departments

Personal Author:

Weiss, Gretchen; Smith, Dawn K.; Newman, Sarah; Wiener, Jeffrey; Kitlas, Alyssa; Hoover, Karen W.;

Published:

Jul 25 2018

Source:

PLoS One. 13(7).

Description:

Objective : The United States Public Health Service released clinical practice guidelines for daily oral preexposure prophylaxis (PrEP) in May 2014. Local health departments (LHDs) are expected to play a critical role in PrEP implementation. We surve...

File Type:

[PDF - 918.78 KB]
Repeated vaginal SHIV challenges in macaques receiving oral or topical Pre-Exposure Prophylaxis induce virus-specific T cell responses

Personal Author:

Tsegaye, Theodros Solomon; Butler, Katherine; Luo, Wei; Radzio, Jessica; Srinivasan, Priya; Sharma, Sunita; Aubert, Rachael D.; Hanson, Debra L.; Dobard, Charles; Garcia-Lerma, J. Gerardo; Heneine, Walid; McNicholl, Janet M.; Kersh, Ellen N.;

Published:

Aug 1 2015

Source:

J Acquir Immune Defic Syndr. 69(4):385-394.

Description:

Background : Pre-Exposure Prophylaxis (PrEP) for HIV prevention is a novel biomedical prevention method. We have previously modeled PrEP during rectal SHIV exposures in macaques and identified that SHIV-specific T cell responses were induced in the p...

File Type:

[PDF - 2.13 MB]
Record of the proceedings : Meeting of the Advisory Council for the Elimination of Tuberculosis, December 2-3, 2014, Atlanta, Georgia

Corporate Author:

Advisory Council for the Elimination of Tuberculosis (U.S.). Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Tuberculosis Elimination..

Published:

2014

Description:

The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Division of Tuberculosis Elimination (DTBE) convened a me...

File Type:

[PDF - 1001.79 KB]